US: Conceptrichtlijn voor verpakkingen en producten zonder PI

21 december 2017

This draft guidance addresses product distribution security provisions in section 582 of the Federal Food, Drug, and Cosmetic Act (FD&C Act). Section 582 was added by the Drug Supply Chain Security Act (DSCSA) and facilitates the tracing of products through the pharmaceutical distribution supply chain by requiring trading partners to exchange information when engaging in transactions involving certain prescription drug products.
Section 582 also requires manufacturers and repackagers to start affixing or imprinting a product identifier to each package and homogenous case of product no later than November 27, 2017 (for manufacturers) and November 27, 2018 (for repackagers) (FDA, november 2017).
Klik hier om het volledige conceptrichtsnoer voor de industrie te downloaden (393 kB).
Klik hier voor meer informatie over het NVC-project Pharmaceutical Packaging Innovation.
Klik hier voor meer informatie over de Live Online NVC E-Course Pharmaceutical Packaging.

Dit bericht is ook opgenomen in ons maandelijkse nieuwsoverzicht, de NVC Members-only Update. Heeft u vragen, neem dan contact met ons op via e-mail of bel: +31-(0)182-512411.